The change in CRP is remarkable.
Oh the versatility and scope for MSB
This may take time but convinced more than ever of the science
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-114
-
- There are more pages in this discussion • 310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.020(2.11%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $3.680M | 3.810M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 149921 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |